Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
For those still thinking about dilution, it is certainly worth repeating zoomboom's 12/31/12 post (#33612) about share structure response from Gerald:
Quote:
--------------------------------------------------------------------------------
Yes Gerald replied yesterday to an Email i sent him on the 28th.
he is a little busy preparing for the conference but he did reply.
this is what he wrote:
"We will be updating the entire market regarding the share structure in the appropriate time. The most recent 10Q has the most up-to-date information available to the market. The Company maintains that it has not entered into any additional financing transactions since the last 10Q, the Company has not sold any shares and none of the officers or directors have sold any shares. Given the data that is upcoming, the officers and directors are precluded from buying shares in the marketplace at this time until the data is released, as that is material non-public information.
Best Regards,
Gerald"
--------------------------------------------------------------------------------
Very, very long AMBS
Certainly worth repeating zoomboom's 12/31/12 post (#33612) about share structure response from Gerald:
Yes Gerald replied yesterday to an Email i sent him on the 28th.
he is a little busy preparing for the conference but he did reply.
this is what he wrote:
"We will be updating the entire market regarding the share structure in the appropriate time. The most recent 10Q has the most up-to-date information available to the market. The Company maintains that it has not entered into any additional financing transactions since the last 10Q, the Company has not sold any shares and none of the officers or directors have sold any shares. Given the data that is upcoming, the officers and directors are precluded from buying shares in the marketplace at this time until the data is released, as that is material non-public information.
Best Regards,
Gerald"
May all the AMBS believers (i.e., longs) have a very Happy New Year! We already know it will be an extremely profitable one.
Be safe and return for the fun Wednesday.
Very, very long AMBS
Not a bad month!
Started December at .0228. Closed December at .132.
Up 479% for the month.
Very, very long AMBS
Old CUSIP shares are replaced by New CUSIP shares.
Very, very long AMBS
I posted this 12/5 (#17151):
A company name change (and the accompanying CUSIP # change) is a great way to shine some light on the degree to which AMBS has been manipulated via Naked Short Shares (NSS). Here is a link to info on CUSIP #s for those unfamiliar with the subject:
www.stockhouse.com/Bullboards/MessageDetailThread.aspx?p=0&m=23494620&r=0&s=FSRT&t=LIST
So, "Would a company name change (and the accompanying CUSIP # change) make NSS have to cover?"
The mechanics of a company name change would effectively prevent trading shares of the old CUSIP # and would create an entirely new set of shares through the DTC. By doing this, the DTC is forced to account for ALL of the old shares exchanged for new shares. Any broker who sold NSS would be responsible for making good on the transaction and covering perhaps forcing a “short squeeze” (price spike) in the NEW CUSIP # shares.
In a conversation with the CUSIP Service Bureau, the rep stated that a CUSIP # change "usually" comes with a name change but not always; however, a name change will "always" come with a CUSIP # change.
A name change starts with the company's Transfer Agent (TA) coordinating electronically with the CUSIP Service Bureau by linking the company's name and address. Then the CUSIP Service Bureau Coordinates with the Depository Trust Company (DTC).
The DTC will serve as the overseer to coordinate with the regulatory authorities and/or agencies, as necessary. The DTC makes sure there is an accurate share accountability for the proper dissemination into brokerage accounts, and this is all done electronically.
After the company (proper/TA/legal team) receives their new CUSIP # from the CUSIP Service Bureau, the company:
• coordinates with the NASDAQ and SEC for the already-coordinated quantity of shares as the new inventory, and
• coordinates with the DTC to confirm the amount of shares and other key info.
After accountability is confirmed by the DTC, the DTC then authorizes the brokerage companies to change all old CUSIP #s to the new CUSIP #s electronically within brokerage accounts.
The CUSIP Service Bureau further explained it as when company 1234 changes its name to company 5678, the shares of company 5678 are given to them electronically by the TA to replace company 1234. This is the key transaction. The name change matching the address of the company is what actually forces an exchange of the "old inventory" of shares to the "new inventory" of shares. Without the name change, there is NOT a "movement of shares." This is a simple misunderstanding by many companies, but, if not considered, it could be the difference for any type of forced covering of NSS positions.
If there is NO DILUTION, a covering of NSS positions should take place due to what is revealed during the accountability process by the DTC after getting the "new inventory" of shares.
This may also explain the recent TA change, too.
Posted yesterday:
For anyone still wondering about the rumor that AMBS had been bought out and changed its symbol to ASCCE, go to:
http://www.dtcc.com/downloads/legal/imp_notices/2012/nscc/otc/OTC-249.pdf
Scroll about halfway down PG 2 SYMBOL CHANGES, and you'll see Aristocrat Group Corp Comm added an E to their symbol...ASCC to ASCCE.
Now, go to PG 3 CUSIP CHANGE...there is AMBS (though they still show on this document the S on Bioscience which we know is not correct).
Information is only as good as it is accurate. Hence no facts for those who do not believe.
Very, very long AMBS
Closes at 4 today.
Received from Scottrade just now:
You are correct in your understanding of the process. We must wait for the new shares to be credited to us. We do not lend the shares prior to receiving them, in the event the terms of the stock update changes. When we receive the shares you will see the # signs removed from your position and the new symbol credited to you. You can then take any action that you wish, on your stock. Thank you for choosing Scottrade. Please let us know if we may be of further assistance.
Very, very long AMBS
GM fellow AMBS shareholders. Looks like AMBS is going to be monster strong ahead. All small dips have been met with buying pressure. I am still holding all my freebies and looking forward to alot more $$$ ahead.
Very, very long AMBS
Everything is still available just now provided by clicking links which take you to the company website. This way, as they update the company website, the information available through ihub is also updated, too.
Very, very long AMBS
??? What page?
Excerpt from CEO Letter to Shareholders dated November 19, 2012:
"...Our management team and Board of Directors remain extremely dedicated to the overall success of the corporation. This is evidenced by every member working without cash consideration since Amarantus became public in the spring of 2011. This has allowed all available resources to be focused on product development."
Sounds like insiders are investing in the company.
Very, very long AMBS
I believe that to be a VERY ASTUTE move on your part to ensure you are not left at the starting gate.
Congratulations on seeing the potential for a momentous 2013 with AMBS. I hope you get filled.
Very, very long AMBS
What kind of leadership and professionalism do we have at AMBS? Here's an indication.
I received this email from Gerald the afternoon of 12/4 in response to an email I sent (my email is at the bottom).
"No problem Victor. I understand what it's like in the heat of the moment. We always have our shareholders interests at heart. I am a major shareholder and this Company represents a lot of sacrifice my family has made to see this come to fruition. Support from folks like yourself have been critical to our recent successes and we will continue to work to make sure that we have your best interests at heart.
Best Regards,
Gerald
Gerald Commissiong
President & CEO
Amarantus BioSciences, Inc.
C/O The Parkinson's Institute
675 Almanor Ave.
Sunnyvale, CA 94085
gerald@amarantus.com"
On Tue, Dec 4, 2012 at 3:01 PM, VMiller
Gerald,
I just wanted to take a moment to extend my sincerest apologies for the last two emails I sent.
You have proven you were productively working on the situation, and you taught me something in turn.
Thank you for a great job!
Respectfully,
Victor Miller
Very, very long AMBS
"We are at a very exciting time here at Amarantus. We have secured the resources and advisors to advance our current assets and expand our business development efforts. We will implement this strategy by honing in on our core program, MANF, and finding innovative solutions to further enable MANF's development and secure Amarantus' ownership of the MANF space. We are encouraged by our data to date, and continue to believe the asset has blockbuster potential.
Your Board of Directors and management team remain dedicated to improving the lives of patients suffering from a variety of illnesses and diseases. We are motivated by the prospects of the company, and our primary focus remains: progressing our assets to help patients and increase shareholder value. I would like to personally thank each of you, and will work to ensure your trust is maintained as Amarantus grows."
Very, very long AMBS
"Perhaps most interesting from a time-to-market standpoint, is the emerging evidence that MANF has activity in certain rare and ultra-rare orphan diseases. The orphan drug strategy that management is pursuing will seek a path to commercialize MANF as expeditiously and cost-effectively as possible, and potentially faster than Parkinson's, Traumatic Brain Injury or Myocardial Infarction. We are evaluating the possibilities of the MANF program in various orphan disease areas through our recent grant from the Center of Excellence for Apoptosis Research and collaborations with academic labs. We expect this process to be completed within a calendar year, and we will be updating shareholders on an on-going basis regarding results of experiments as data becomes available. The key advantage to this strategy is that the Investigational New Drug (IND) protocols required for our Parkinson's program will overlap with our orphan drug program; therefore, an additional IND should be attainable in the same timeframe."
Very, very long AMBS
Potential multi-billion dollar company in the making:
1) First test ever for Parkinsonism.
2) First test ever for Alzheimers disease.
3) Possible drug to cure Parkinsonism.
4) Drug to HEAL heart damage maybe up to 40% in heart attack victims.
5) Possible drug to heal stroke victims.
6) Dr. Joseph Rubinfeld, Amgen Co Founder states, "I believe in MANF. I have reviewed a great number of technologies in my 45 year career in the biopharmaceutical field, and I believe that MANF could be one of the biggest successes that I have ever seen. The fundamental scientific premise of reducing protein misfolding is basic, yet very profound. The data, while early, demonstrates very clearly at the cellular level and in animals that MANF reduces apoptosis, improves cellular function, and restores behavioural deficits in a number of disease models, including Parkinson's, Stroke, Myocardial Infarction and Traumatic Brain Injury. These are all indications with very large markets and clear unmet medical need. I believe that if we are able to further de-risk MANF with positive toxicology studies and early clinical data, the Company's new orphan drug strategy could get MANF to market rather expeditiously. MANF has the commercial potential to become a blockbuster drug."
Very, very long AMBS
The credentials/qualifications of ihub's AMBS stock board posters are immaterial to the value (current and potential) of Amarantus. The only credentials/qualifications people should be concerned with are those of AMBS's management team and advisors.
However, since it is YOUR own money being invested, ultimately you are THE ONLY ONE you should listen to based on your circumstances. Should you find someone you think has opinions worth listening to, part of your due diligence should ALSO include research into the background/personality on "your new friend and advisor."
Very, very long AMBS
The following link shows it concerned Ironridge Global (scroll to bottom):
http://investors.morningstar.com/ownership/shareholders-overview.html?t=AMBS®ion=USA&culture=en-us
Here's the link to the 13G filed on EDGAR:
http://www.sec.gov/Archives/edgar/data/1424812/000114420412061618/v328243_sc13g.htm
Sounds like another absolutely accurate purpose/reason for the TA not to give out share structure info to anyone who calls.
Very, very long AMBS
Use the following for any stock you would wish to do some DD on. Click link, type in company name, click find companies and voila...all SEC filings for the company requested.
http://www.sec.gov/edgar/searchedgar/companysearch.html
It is always best to get info from the most reliable source possible, and EDGAR is the one you want for such things.
Very, very long AMBS
I posted this 12/5 (#17151):
A company name change (and the accompanying CUSIP # change) is a great way to shine some light on the degree to which AMBS has been manipulated via Naked Short Shares (NSS). Here is a link to info on CUSIP #s for those unfamiliar with the subject:
www.stockhouse.com/Bullboards/MessageDetailThread.aspx?p=0&m=23494620&r=0&s=FSRT&t=LIST
So, "Would a company name change (and the accompanying CUSIP # change) make NSS have to cover?"
The mechanics of a company name change would effectively prevent trading shares of the old CUSIP # and would create an entirely new set of shares through the DTC. By doing this, the DTC is forced to account for ALL of the old shares exchanged for new shares. Any broker who sold NSS would be responsible for making good on the transaction and covering perhaps forcing a “short squeeze” (price spike) in the NEW CUSIP # shares.
In a conversation with the CUSIP Service Bureau, the rep stated that a CUSIP # change "usually" comes with a name change but not always; however, a name change will "always" come with a CUSIP # change.
A name change starts with the company's Transfer Agent (TA) coordinating electronically with the CUSIP Service Bureau by linking the company's name and address. Then the CUSIP Service Bureau Coordinates with the Depository Trust Company (DTC).
The DTC will serve as the overseer to coordinate with the regulatory authorities and/or agencies, as necessary. The DTC makes sure there is an accurate share accountability for the proper dissemination into brokerage accounts, and this is all done electronically.
After the company (proper/TA/legal team) receives their new CUSIP # from the CUSIP Service Bureau, the company:
• coordinates with the NASDAQ and SEC for the already-coordinated quantity of shares as the new inventory, and
• coordinates with the DTC to confirm the amount of shares and other key info.
After accountability is confirmed by the DTC, the DTC then authorizes the brokerage companies to change all old CUSIP #s to the new CUSIP #s electronically within brokerage accounts.
The CUSIP Service Bureau further explained it as when company 1234 changes its name to company 5678, the shares of company 5678 are given to them electronically by the TA to replace company 1234. This is the key transaction. The name change matching the address of the company is what actually forces an exchange of the "old inventory" of shares to the "new inventory" of shares. Without the name change, there is NOT a "movement of shares." This is a simple misunderstanding by many companies, but, if not considered, it could be the difference for any type of forced covering of NSS positions.
If there is NO DILUTION, a covering of NSS positions should take place due to what is revealed during the accountability process by the DTC after getting the "new inventory" of shares.
This may also explain the recent TA change, too.
Here are several possible "answers" to your question:
Some may be selling small pieces of their holdings in the hopes of instilling fear from others then buying back bigger volume to add to their stakes, or
they aren't really selling as much as MMs are playing games, or
Shorts/NSS.
Very, very long AMBS
For anyone still wondering about the rumor that AMBS had been bought out and changed its symbol to ASCCE, go to:
http://www.dtcc.com/downloads/legal/imp_notices/2012/nscc/otc/OTC-249.pdf
Scroll about halfway down PG 2 SYMBOL CHANGES, and you'll see Aristocrat Group Corp Comm added an E to their symbol...ASCC to ASCCE.
Now, go to PG 3 CUSIP CHANGE...there is AMBS (though they still show on this document the S on Bioscience which we know is not correct).
Information is only as good as it is accurate. Hence no facts for those who do not believe.
Very, very long AMBS
Sounds like many posts on here.
The credentials/qualifications of ihub's AMBS stock board posters are immaterial to the value (current and potential) of Amarantus. The only credentials/qualifications people should be concerned with are those of AMBS's management team and advisors.
However, since it is YOUR own money being invested, ultimately you are THE ONLY ONE you should listen to based on your circumstances. Should you find someone you think has opinions worth listening to, part of your due diligence should ALSO include research into the background/personality on "your new friend and advisor."
Very, very long AMBS
Asked and answered. Most penny stocks are scams. This is a company who stock is valued in the pennies...TEMPORARILY!
Very, very long AMBS
It IS contained in the intro box (scroll down page and click Edgar Filings) and numerous posters have listed the edgar site in their posts.
Very, very long AMBS
Share structure listed on Yahoo Finance (as of 12/29/12):
A/S: 1 B
O/S: 224.26 M
Float: 159.56 M
Link provided below for verification and further details.
http://finance.yahoo.com/q/ks?s=AMBS+Key+Statistics
Based on these figures, the O/S stayed the same and the float DECREASED by 14 M from the previously published Yahoo Finance numbers.
Very, very long AMBS
I posted this 12/5 (#17151):
A company name change (and the accompanying CUSIP # change) is a great way to shine some light on the degree to which AMBS has been manipulated via Naked Short Shares (NSS). Here is a link to info on CUSIP #s for those unfamiliar with the subject:
www.stockhouse.com/Bullboards/MessageDetailThread.aspx?p=0&m=23494620&r=0&s=FSRT&t=LIST
So, "Would a company name change (and the accompanying CUSIP # change) make NSS have to cover?"
The mechanics of a company name change would effectively prevent trading shares of the old CUSIP # and would create an entirely new set of shares through the DTC. By doing this, the DTC is forced to account for ALL of the old shares exchanged for new shares. Any broker who sold NSS would be responsible for making good on the transaction and covering perhaps forcing a “short squeeze” (price spike) in the NEW CUSIP # shares.
In a conversation with the CUSIP Service Bureau, the rep stated that a CUSIP # change "usually" comes with a name change but not always; however, a name change will "always" come with a CUSIP # change.
A name change starts with the company's Transfer Agent (TA) coordinating electronically with the CUSIP Service Bureau by linking the company's name and address. Then the CUSIP Service Bureau Coordinates with the Depository Trust Company (DTC).
The DTC will serve as the overseer to coordinate with the regulatory authorities and/or agencies, as necessary. The DTC makes sure there is an accurate share accountability for the proper dissemination into brokerage accounts, and this is all done electronically.
After the company (proper/TA/legal team) receives their new CUSIP # from the CUSIP Service Bureau, the company:
• coordinates with the NASDAQ and SEC for the already-coordinated quantity of shares as the new inventory, and
• coordinates with the DTC to confirm the amount of shares and other key info.
After accountability is confirmed by the DTC, the DTC then authorizes the brokerage companies to change all old CUSIP #s to the new CUSIP #s electronically within brokerage accounts.
The CUSIP Service Bureau further explained it as when company 1234 changes its name to company 5678, the shares of company 5678 are given to them electronically by the TA to replace company 1234. This is the key transaction. The name change matching the address of the company is what actually forces an exchange of the "old inventory" of shares to the "new inventory" of shares. Without the name change, there is NOT a "movement of shares." This is a simple misunderstanding by many companies, but, if not considered, it could be the difference for any type of forced covering of NSS positions.
If there is NO DILUTION, a covering of NSS positions should take place due to what is revealed during the accountability process by the DTC after getting the "new inventory" of shares.
This may also explain the recent TA change, too.
Very, very long AMBS
Received the following from Scottrade today about the ongoing CUSIP share change out:
"Amarantus Biosciences Inc (AMBS) is processing a 1 for 1 CUSIP change on their outstanding shares. This is a mandatory corporate action that affects all shareholders. Shareholders will retain the same number of company shares after the change is completed.
A CUSIP is an identification number assigned to all stocks and registered bonds. The Committee on Uniform Securities Identification Procedures (CUSIP) oversees the entire CUSIP system. This system is used in the U.S. and Canada. Foreign securities have a similar number called the "CINS number".
Although the company name and trading symbol are remaining the same, this involves actually exchanging the old AMBS shares for new ones. At this time, we do not have an anticipated delivery date for the new shares. Scottrade will not post the new shares to client accounts until they are actually received. Until that time, existing positions will display with the symbol AMBS## and will not display share price updates.
Scottrade clients will not be able to sell their new shares until they are actually received. Your patience in this matter is greatly appreciated.
Thank you for choosing Scottrade. Please let us know if we may be of further assistance."
Looks like the physical exchange of old shares to new shares may be ongoing into 2013.
Very, very long AMBS
News/Events does NOT apply only to the upcoming conference where they will deliver excellent news. Many, many other things fall into the news/events category.
Very, very long AMBS
I think news/events come into play, too, and can trump charts!
Very, very long AMBS
So if they go on algorithms, and it could be a weekly one next...looking great for AMBS as we approach the conference..., could see .15+ by Wednesday...
Very, very long AMBS
New CUSIP shares could be bought and sold today, but not old CUSIP shares. Read any number of a couple dozen posts from many people throughout the day and covering numerous brokerage houses.
Very, very long AMBS
Except...
old shares are locked up at this time due to CUSIP change.
Very, very long AMBS
Originally posted by cjstocksup 12/26 (#27441):
"AMBS shares getting accumulated by new and far wiser money for the big $$$ ahead."
Never has a more accurate statement been posted.
Very, very long AMBS
Thanks. Doesn't sound like dilution to me.
Very, very long AMBS